Literature DB >> 22734496

Cytokine and chemokine responses in pediatric patients with severe pneumonia associated with pandemic A/H1N1/2009 influenza virus.

Yuji Matsumoto1, Yoshiki Kawamura, Hidetaka Nakai, Ken Sugata, Akiko Yoshikawa, Masaru Ihira, Masahiro Ohashi, Tomochika Kato, Tetsushi Yoshikawa.   

Abstract

Severe pneumonia and leukocytosis are characteristic, frequently observed, clinical findings in pediatric patients with pandemic A/H1N1/2009 influenza virus infection. The aim of this study was to elucidate the role of cytokines and chemokines in complicating pneumonia and leukocytosis in patients with pandemic A/H1N1/2009 influenza virus infection. Forty-seven patients with pandemic A/H1N1/2009 influenza virus infection were enrolled in this study. Expression of interleukin (IL)-10 (P = 0.027) and IL-5 (P = 0.014) was significantly greater in patients with pneumonia than in those without pneumonia. Additionally, serum concentrations of interferon-γ (P = 0.009), tumor necrosis factor-α (P = 0.01), IL-4 (P = 0.024), and IL-2 (P = 0.012) were significantly lower in pneumonia patients with neutrophilic leukocytosis than in those without neutrophilic leukocytosis. Of the five serum chemokine concentrations assessed, only IL-8 was significantly lower in pneumonia patients with neutrophilic leukocytosis than in those without leukocytosis (P = 0.001). These cytokines and chemokines may play important roles in the pathogenesis of childhood pneumonia associated with A/H1N1/2009 influenza virus infection.
© 2012 The Societies and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22734496     DOI: 10.1111/j.1348-0421.2012.00489.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  10 in total

1.  Clinical aspects and cytokine response in adults with seasonal influenza infection.

Authors:  Jia-Rong Bian; Wei Nie; Yuan-Sheng Zang; Zheng Fang; Qing-Yu Xiu; Xing-Xiang Xu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Cytokine Concentrations in Plasma from Children with Severe and Non-Severe Community Acquired Pneumonia.

Authors:  Johanne Haugen; Ram K Chandyo; Karl A Brokstad; Maria Mathisen; Manjeswori Ulak; Sudha Basnet; Palle Valentiner-Branth; Tor A Strand
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

3.  Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice.

Authors:  Nobuyuki Nosaka; Masato Yashiro; Mutsuko Yamada; Yosuke Fujii; Hirokazu Tsukahara; Keyue Liu; Masahiro Nishibori; Akihiro Matsukawa; Tsuneo Morishima
Journal:  Crit Care       Date:  2015-06-11       Impact factor: 9.097

4.  Molecular analysis of serum and bronchoalveolar lavage in a mouse model of influenza reveals markers of disease severity that can be clinically useful in humans.

Authors:  Yadunanda Kumar; Cui Liang; Gino V Limmon; Li Liang; Bevin P Engelward; Eng Eong Ooi; Jianzhu Chen; Steven R Tannenbaum
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

5.  Pregnant women infected with pandemic H1N1pdm2009 influenza virus displayed overproduction of peripheral blood CD69+ lymphocytes and increased levels of serum cytokines.

Authors:  Arturo Cérbulo-Vázquez; Ricardo Figueroa-Damián; Lourdes A Arriaga-Pizano; Edgar Hernández-Andrade; Ismael Mancilla-Herrera; Luis Angel Flores-Mejía; Gabriel Arteaga-Troncoso; Constantino López-Macías; Armando Isibasi; Javier Mancilla-Ramírez
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

6.  Comparative Safety and Efficacy Profile of a Novel Oil in Water Vaccine Adjuvant Comprising Vitamins A and E and a Catechin in Protective Anti-Influenza Immunity.

Authors:  Sapna Patel; Yasser Faraj; Debra K Duso; William W Reiley; Erik A Karlsson; Stacey Schultz-Cherry; Michael Vajdy
Journal:  Nutrients       Date:  2017-05-21       Impact factor: 5.717

7.  Interleukin-5, interleukin-6, interferon induced protein-10, procalcitonin and C-reactive protein among mechanically ventilated severe community-acquired viral and bacterial pneumonia patients.

Authors:  Jaana Karhu; Tero Ilmari Ala-Kokko; Tytti Vuorinen; Pasi Ohtonen; Ilkka Julkunen; Hannu Tapani Syrjälä
Journal:  Cytokine       Date:  2018-07-25       Impact factor: 3.861

8.  Early Amplified Respiratory Bioactive Lipid Response Is Associated With Worse Outcomes in Pediatric Influenza-Related Respiratory Failure.

Authors:  Veronica G Anania; Adrienne G Randolph; Xiaoying Yang; Allen Nguyen; Margaret M Newhams; W Rodney Mathews; Carrie M Rosenberger; Jacqueline M McBride
Journal:  Open Forum Infect Dis       Date:  2020-04-09       Impact factor: 3.835

9.  Immunophenotype expressions and cytokine profiles of influenza A H1N1 virus infection in pediatric patients in 2009.

Authors:  Shih-Min Wang; Yu-Ting Liao; Yu-Shiang Hu; Tzong-Shiann Ho; Ching-Fen Shen; Jen-Ren Wang; Yee-Shin Lin; Ching-Chuan Liu
Journal:  Dis Markers       Date:  2014-02-18       Impact factor: 3.434

10.  Specific Cytokine Profiles Predict the Severity of Influenza A Pneumonia: A Prospectively Multicenter Pilot Study.

Authors:  Yu Xie; Yan Yu; Lili Zhao; Pu Ning; Qiongzhen Luo; Ying Zhang; Lu Yin; Yali Zheng; Zhancheng Gao
Journal:  Biomed Res Int       Date:  2021-10-13       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.